Stem cell injections are a form of regenerative medicine in which stem cells are delivered into damaged or diseased tissue with the goal of repairing it. The average cost in the U.S. is around $10,000, insurance rarely covers it, and most uses remain experimental. While bone marrow transplants for blood cancers have been standard medicine for decades, the growing market of stem cell injections for joint pain, back injuries, and neurological conditions sits in a gray area between promising science and unproven hype.
How Stem Cells Work in the Body
Stem cells have two defining traits: they can copy themselves indefinitely, and they can mature into specialized cell types like bone, cartilage, muscle, or nerve cells. The idea behind stem cell injections is straightforward. Deliver these versatile cells to a damaged area, and they’ll either replace worn-out tissue or kickstart your body’s own healing process.
In practice, the biology is more complicated. Scientists still struggle to reliably direct stem cells to become specific cell types. And research suggests the benefit may not even come primarily from new cells integrating into tissue. Instead, injected stem cells appear to release signaling molecules (a process called paracrine signaling) that reduce inflammation, protect surrounding cells from dying, and recruit your body’s own repair mechanisms. In heart studies, for example, gains in function were found to be more likely due to these chemical signals benefiting existing heart cells than from new heart cells actually growing in place.
Types of Stem Cells Used
There are two broad categories. Pluripotent stem cells can become virtually any cell type in the adult body. Multipotent stem cells are more limited, capable of developing into only a narrower range of cell types. Most injection-based therapies today use multipotent mesenchymal stem cells, which can give rise to bone, cartilage, fat, and connective tissue.
Where those cells come from matters. In autologous procedures, stem cells are harvested from your own body, typically through a bone marrow aspiration from the hip (iliac crest) or extracted from your own fat tissue. The advantage is zero risk of immune rejection since they’re your own cells. In allogeneic procedures, stem cells come from a donor, often from umbilical cord tissue or placental tissue collected after birth. Donor cells are easier to obtain in large quantities but carry a small risk of immune reactions.
What the Procedure Looks Like
For autologous injections, the process has two phases. First, your cells are harvested. In a bone marrow aspiration, a needle is inserted into your hip bone under local or general anesthesia. The collected marrow is then filtered, spun in a centrifuge to separate and concentrate the stem cells, and prepared for injection. This processing can take anywhere from 30 minutes to several hours depending on the technique.
The injection itself is typically guided by ultrasound or fluoroscopy so the cells reach the precise target, whether that’s a knee joint, a spinal disc, or a tendon. Certain joints like ankles, thumbs, and toes tend to be more painful to inject. You can expect varying degrees of pain in the first few days, and mild to moderate discomfort can last up to two weeks. Recovery involves resting for the first 24 to 48 hours without being completely sedentary, then starting physical therapy within four to six days.
Evidence for Knee Osteoarthritis
Knee osteoarthritis is one of the most studied applications. A Cochrane review analyzing seven studies and over 400 participants found that at six months, stem cell injections reduced pain by an average of 1.2 points on a 0-to-10 scale compared to placebo. Function improved by about 14 points on a 0-to-100 scale. At 12 months, 68% of people who received stem cell injections rated their treatment a success, compared to 53% who received placebo injections.
Those numbers are real but modest. A 1.2-point pain improvement is noticeable for some people and barely perceptible for others. The wide variability across studies (shown by high statistical inconsistency scores of 80% or more) means individual results differ significantly. Some people experience substantial relief; others notice little change.
How Stem Cells Compare to PRP
Platelet-rich plasma (PRP) is another regenerative injection you’ll often see mentioned alongside stem cells. PRP is simpler and cheaper. It’s made by drawing your blood, spinning it to concentrate the platelets, and injecting the resulting solution. The whole process takes under an hour. PRP relies on growth factors from platelets to stimulate healing, but it doesn’t contain stem cells and cannot replace damaged cells the way stem cell therapy theoretically can.
The regenerative potential of PRP is limited to supporting cells already present in the tissue. Stem cell therapy, at least in concept, can address conditions where the tissue itself is too degraded for PRP to help. That said, PRP is far better established, less expensive (typically a few hundred to a couple thousand dollars), and carries fewer risks. For many orthopedic injuries, PRP is tried first.
Risks and Safety Concerns
Stem cell injections are not risk-free. The most commonly discussed concerns fall into three categories.
Infection is a risk with any injection, but stem cell preparations add complexity. Donor-derived cells can harbor viruses even after standard screening. One analysis found viral genetic material in a significant portion of donor cell samples, with common viruses detected in over 60% of cases. Bacterial contamination during the cell culturing process, particularly from mycoplasma, is another recognized threat.
Immune reactions are possible, especially with donor-derived cells. While mesenchymal stem cells were once thought to be “immune privileged,” meaning invisible to the immune system, research has shown they can still trigger systemic immune responses. In some cases, the immune-suppressing properties of these cells have actually increased the risk of serious infections like pneumonia after transplantation.
Abnormal cell growth is the most alarming risk. One laboratory study found that roughly 46% of human mesenchymal stem cells underwent spontaneous transformation resembling cancer cells after four weeks in culture. When those transformed cells were implanted in mice, they formed tumors. In a large clinical study tracking 2,372 patients who received stem cell injections for joint disease, seven cases of new tumors were reported, an incidence of about 0.3%. Chromosomal abnormalities in cultured stem cells increase significantly the longer cells are grown in the lab, which is why manufacturing controls are critical.
Who Is and Isn’t a Candidate
People with moderate joint degeneration, chronic tendon injuries, or certain inflammatory conditions are the most common candidates. The ideal patient generally has a condition that hasn’t progressed so far that the tissue is beyond biological repair but hasn’t responded well enough to conventional treatments like physical therapy or corticosteroid injections.
Several conditions disqualify someone from treatment: active cancer, a history of bone marrow cancer, active infections, severe anemia, or blood-related diseases. Age and overall health status also play a role in determining eligibility, since older or sicker patients may not produce stem cells robust enough for effective therapy.
Cost and Insurance Coverage
Stem cell injections are expensive and almost entirely out of pocket. The average cost in the U.S. is approximately $10,000, though prices vary widely by condition and body part. Knee injections typically range from $5,000 to $10,000. Back and shoulder treatments run $5,000 to $15,000. Vision-related stem cell procedures start around $20,000 and go higher. Many patients pay well over $20,000 depending on the clinic and protocol.
Private insurance generally does not cover stem cell injections for orthopedic or regenerative purposes. Medicare covers established bone marrow transplants for blood cancers and similar conditions but does not cover unproven stem cell therapies. This financial reality leads some patients to travel abroad or take on significant debt, which is worth factoring into any decision.
What’s Approved and What Isn’t
The only stem cell therapies with full regulatory approval in the U.S. are bone marrow transplants (hematopoietic stem cell transplants) for blood cancers and certain immune disorders, along with a small number of cord blood products for similar uses. The vast majority of stem cell injections offered at clinics for joint pain, back injuries, neurological conditions, anti-aging, and other purposes are not FDA-approved for those uses. Many operate under regulatory exemptions or in legal gray zones. This doesn’t automatically mean they don’t work, but it does mean the evidence supporting them hasn’t met the standard required for formal approval.